For Firms & Investors
Because we've sat on both sides — R&D and industry operations — we're a strong partner for established firms and funds. Enter a bio-based sector, evaluate an acquisition, or stand up in-house capability with operator accountability.
Market Entry
- Build-vs-Buy sprints (2–4 weeks)
- Capability maps & vendor shortlists
- Pilot line definition & budget
M&A Technical DD
- TRL/CMC truthing, red flags
- USP/DSP validation; CoGS v1
- 90-day integration plan
In-house Innovation
- Program charter & milestones
- Team & lab/pilot configuration
- Governance & decision cadence
Risk & Regulation
- GMP/GxP gap assessment
- QA/QC system design
- Authority interfaces (FDA-minded)